SCICLONE PHARMACEUTICALS INC Restructuring Charges
SCICLONE PHARMACEUTICALS INC reported Restructuring Charges of $1.18 million for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2016-03-11
- SCICLONE PHARMACEUTICALS INC restructuring charges for fiscal 2013 was $1.18M, a 7.76% increase from fiscal 2012.
- SCICLONE PHARMACEUTICALS INC restructuring charges for fiscal 2012 was $1.10M.
| Period end | Restructuring Charges 12 month |
|---|---|
| 2013-12-31 | $1.18M 10-K · filed 2016-03-11 |
| 2012-12-31 | $1.10M 10-K · filed 2015-03-12 |